Advanced Infusion Services is a provider of infusion services and pharmaceuticals based in the United States. It offers infusion therapy services, including medication administration, patient education, and education on infusion therapy equipment usage, as well as pharmaceutical products and services, including compounding, formulary management, and drug distribution.
The global Advanced Infusion Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淎dvanced Infusion Services Industry Forecast鈥 looks at past sales and reviews total world Advanced Infusion Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Advanced Infusion Services sales for 2023 through 2029. With Advanced Infusion Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Advanced Infusion Services industry.
This Insight Report provides a comprehensive analysis of the global Advanced Infusion Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Advanced Infusion Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global Advanced Infusion Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Advanced Infusion Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Advanced Infusion Services.
United States market for Advanced Infusion Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Advanced Infusion Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Advanced Infusion Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Advanced Infusion Services players cover ADVance Care Pharmacy, AIS Healthcare, Harris Williams, Redica Systems, Advanced Healthcare Logistics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Advanced Infusion Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Anti-Infectives
Endocrinology
Enteral Nutrition
Chemotherapy
Segmentation by Application:
Hospital
Medical Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Anti-Infectives
Endocrinology
Enteral Nutrition
Chemotherapy
Segmentation by Application:
Hospital
Medical Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ADVance Care Pharmacy
AIS Healthcare
Harris Williams
Redica Systems
Advanced Healthcare Logistics
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Advanced Infusion Services 麻豆原创 Size 2019-2030
2.1.2 Advanced Infusion Services 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Advanced Infusion Services by Country/Region, 2019, 2023 & 2030
2.2 Advanced Infusion Services Segment by Type
2.2.1 Anti-Infectives
2.2.2 Endocrinology
2.2.3 Enteral Nutrition
2.2.4 Chemotherapy
2.3 Advanced Infusion Services 麻豆原创 Size by Type
2.3.1 Advanced Infusion Services 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Advanced Infusion Services 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Advanced Infusion Services Segment by Application
2.4.1 Hospital
2.4.2 Medical Institutions
2.5 Advanced Infusion Services 麻豆原创 Size by Application
2.5.1 Advanced Infusion Services 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Advanced Infusion Services 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Advanced Infusion Services 麻豆原创 Size by Player
3.1 Advanced Infusion Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Advanced Infusion Services Revenue by Player (2019-2024)
3.1.2 Global Advanced Infusion Services Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Advanced Infusion Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Advanced Infusion Services by Region
4.1 Advanced Infusion Services 麻豆原创 Size by Region (2019-2024)
4.2 Global Advanced Infusion Services Annual Revenue by Country/Region (2019-2024)
4.3 Americas Advanced Infusion Services 麻豆原创 Size Growth (2019-2024)
4.4 APAC Advanced Infusion Services 麻豆原创 Size Growth (2019-2024)
4.5 Europe Advanced Infusion Services 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Advanced Infusion Services 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Advanced Infusion Services 麻豆原创 Size by Country (2019-2024)
5.2 Americas Advanced Infusion Services 麻豆原创 Size by Type (2019-2024)
5.3 Americas Advanced Infusion Services 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Advanced Infusion Services 麻豆原创 Size by Region (2019-2024)
6.2 APAC Advanced Infusion Services 麻豆原创 Size by Type (2019-2024)
6.3 APAC Advanced Infusion Services 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Advanced Infusion Services 麻豆原创 Size by Country (2019-2024)
7.2 Europe Advanced Infusion Services 麻豆原创 Size by Type (2019-2024)
7.3 Europe Advanced Infusion Services 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Advanced Infusion Services by Region (2019-2024)
8.2 Middle East & Africa Advanced Infusion Services 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Advanced Infusion Services 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Advanced Infusion Services 麻豆原创 Forecast
10.1 Global Advanced Infusion Services Forecast by Region (2025-2030)
10.1.1 Global Advanced Infusion Services Forecast by Region (2025-2030)
10.1.2 Americas Advanced Infusion Services Forecast
10.1.3 APAC Advanced Infusion Services Forecast
10.1.4 Europe Advanced Infusion Services Forecast
10.1.5 Middle East & Africa Advanced Infusion Services Forecast
10.2 Americas Advanced Infusion Services Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Advanced Infusion Services Forecast
10.2.2 Canada 麻豆原创 Advanced Infusion Services Forecast
10.2.3 Mexico 麻豆原创 Advanced Infusion Services Forecast
10.2.4 Brazil 麻豆原创 Advanced Infusion Services Forecast
10.3 APAC Advanced Infusion Services Forecast by Region (2025-2030)
10.3.1 China Advanced Infusion Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Advanced Infusion Services Forecast
10.3.3 Korea 麻豆原创 Advanced Infusion Services Forecast
10.3.4 Southeast Asia 麻豆原创 Advanced Infusion Services Forecast
10.3.5 India 麻豆原创 Advanced Infusion Services Forecast
10.3.6 Australia 麻豆原创 Advanced Infusion Services Forecast
10.4 Europe Advanced Infusion Services Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Advanced Infusion Services Forecast
10.4.2 France 麻豆原创 Advanced Infusion Services Forecast
10.4.3 UK 麻豆原创 Advanced Infusion Services Forecast
10.4.4 Italy 麻豆原创 Advanced Infusion Services Forecast
10.4.5 Russia 麻豆原创 Advanced Infusion Services Forecast
10.5 Middle East & Africa Advanced Infusion Services Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Advanced Infusion Services Forecast
10.5.2 South Africa 麻豆原创 Advanced Infusion Services Forecast
10.5.3 Israel 麻豆原创 Advanced Infusion Services Forecast
10.5.4 Turkey 麻豆原创 Advanced Infusion Services Forecast
10.6 Global Advanced Infusion Services Forecast by Type (2025-2030)
10.7 Global Advanced Infusion Services Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Advanced Infusion Services Forecast
11 Key Players Analysis
11.1 ADVance Care Pharmacy
11.1.1 ADVance Care Pharmacy Company Information
11.1.2 ADVance Care Pharmacy Advanced Infusion Services Product Offered
11.1.3 ADVance Care Pharmacy Advanced Infusion Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 ADVance Care Pharmacy Main Business Overview
11.1.5 ADVance Care Pharmacy Latest Developments
11.2 AIS Healthcare
11.2.1 AIS Healthcare Company Information
11.2.2 AIS Healthcare Advanced Infusion Services Product Offered
11.2.3 AIS Healthcare Advanced Infusion Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 AIS Healthcare Main Business Overview
11.2.5 AIS Healthcare Latest Developments
11.3 Harris Williams
11.3.1 Harris Williams Company Information
11.3.2 Harris Williams Advanced Infusion Services Product Offered
11.3.3 Harris Williams Advanced Infusion Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Harris Williams Main Business Overview
11.3.5 Harris Williams Latest Developments
11.4 Redica Systems
11.4.1 Redica Systems Company Information
11.4.2 Redica Systems Advanced Infusion Services Product Offered
11.4.3 Redica Systems Advanced Infusion Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Redica Systems Main Business Overview
11.4.5 Redica Systems Latest Developments
11.5 Advanced Healthcare Logistics
11.5.1 Advanced Healthcare Logistics Company Information
11.5.2 Advanced Healthcare Logistics Advanced Infusion Services Product Offered
11.5.3 Advanced Healthcare Logistics Advanced Infusion Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Advanced Healthcare Logistics Main Business Overview
11.5.5 Advanced Healthcare Logistics Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.